Abstract:182 Background: Cell replacement with induced pluripotent stem cell-derived midbrain dopaminergic neuronal grafts (iPSC-mDA) is a promising therapeutic strategy for Parkinson’s disease (PD). Without the aid of immunosuppression, use of allogeneic iPSC-mDA (obtained from a donor) in therapy may trigger an immune response leading to increased neuroinflammation at the site of the grafts. Compared to allogeneic iPSC-mDA, cell replacement with autologous iPSC-mDA (obtained from the same individual) should not trigger this response. Objectives: The purpose of this study was to assess in vivo using the PET TSPO radiotracer, [18F]FEPPA, whether rhesus subjects treated with autologous or allogeneic iPSC-mDA show increased microglial activation (a biomarker for neuroinflammation) at the graft sites. Methods: The present study was performed in strict accordance with the recommendations in the NIH Guide for the Care and Use of Laboratory Animals. Experimental procedures were approved by the IACUC of the University of Wisconsin-Madison. Ten adult male rhesus macaques received a unilateral (right) intracarotid artery injection of the neurotoxin MPTP under sterile surgical conditions and isoflurane anesthesia. Six to eight months later, four primates received autologous iPSC-mDA and six primates received allogeneic iPSC-mDA to the ipsilateral (right) putamen. Cell delivery was performed using real-time intraoperative MRI (IMRI) in a 3-T GE SIGNA MRI scanner. Twenty four months following surgery, the primates underwent 120-minute dynamic [18F]FEPPA scans in a microPET Focus 220 scanner. Region of interest (ROI) masks were generated for each iPSC-mDA graft site through segmentation of the IMRI data (Figure 1). ROIs for the left putamen (control region) and cerebellum (unaffected by surgery) were generated from an in-house rhesus atlas. The ROIs were registered to the [18F]FEPPA PET data to extract time-activity curves, and 90-120 minute summed PET frames were used to generate an asymmetry index (L-R)/(L+R)/2 for the ROIs to assess hemispheric differences of [18F]FEPPA uptake. Results: Average time-activity curves (Figure 2) for primates with allogeneic and autologous iPSC-mDA grafts reveal disparity in the uptake of [18F]FEPPA at the site of the grafts between groups. On average, primates with allogeneic grafts show increased uptake at the graft sites relative to the control, whereas no difference is observed with the autologous grafts. Table 1 displays the asymmetry indices for the putamen and cerebellum. From the asymmetry analysis, primates with allogeneic grafts show significant asymmetry of [18F]FEPPA uptake in the putamen compared to primates with autologous grafts (two-sample t-test: p Conclusions: Our results demonstrate that [18F]FEPPA PET can be used as an in vivo biomarker of neuroinflammation after autologous or allogeneic iPSC-mDA intracerebral grafts. Post mortem analysis of the brains, including evaluation of CD68 immunoreactivity as a marker of microglia recruitment, is currently underway to validate the PET data.

Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

11 C-NMSP/ 18 F-FDG Micropet to Monitor Neural Stem Cell Transplantation in a Rat Model of Traumatic Brain Injury

In vivo PET imaging of implanted cells in a Parkinson's disease rat model

Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

Pet Demonstrates Functional Recovery after Transplantation of Induced Pluripotent Stem Cells in A Rat Model of Cerebral Ischemic Injury

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Differentiation of Adult Human Retinal Pigment Epithelial Cells into Dopaminergic-Like Cells in Vitro and in the Recipient Monkey Brain

Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson’s disease

Xenotransplantation of microencapsulated bovine retinal pigment epithelial cells into parkinsonian rats

[18f]Feppa Pet Imaging For Monitoring Neuroinflammation In Nonhuman Primates

Measuring Neuroinflammation in Hemiparkinsonian Rhesus Treated with Ipsc-Derived Dopaminergic Neuronal Grafts Using [F-18]FEPPA PET

In Vivo Detection of Monoaminergic Degeneration in Lipopolysaccharide-Induced Rat Model of Parkinson's Disease Using 18F-FP-(+)-DTBZ (18F-AV-133) PET

In Vivo Subretinal ARPE-19 Cell Tracking Using Indocyanine Green Contrast-Enhanced Multimodality Photoacoustic Microscopy, Optical Coherence Tomography, and Fluorescence Imaging for Regenerative Medicine

[Positron Emission Tomography Imaging of Cell Transplantation in a Rat Model of Alzheimer's Disease].

In Vivo Imaging of Retinal Gliosis: a Platform for Diagnosis of PD and Screening of Anti-Pd Compounds.

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

Using PET Methods to Evaluate Induced Pluripotent Stem Cell-Derived Neuronal Function

In Vivo Visualization and Monitoring of Viable Neural Stem Cells Using Noninvasive Bioluminescence Imaging in the 6-Hydroxydopamine-Induced Mouse Model of Parkinson Disease

Experimental study on the xenotransplantation of microencapsulated bovine retinal pigmentary epithelial cells into Parkinsonian rats with lewy bodies

Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using 18F-fallypride micro-positron emission tomography scanning